Inventor
RICHARD THOMAS BERESIS
Inventor
CN
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
A61KPreparations for medical, dental or toiletry purposes31%
C07JSteroids23%
C07DHeterocyclic compounds12%
PatentTitleYear
12,378,255Toll-like receptor antagonist compounds and methods of use202512,201,64019-nor C3,3-disubstituted C21-n-pyrazolyl steroids and methods of use thereof202511,945,836Compositions and methods for treating CNS disorders202411,912,73719-nor neuroactive steroids and methods of use thereof202411,827,641Toll-like receptor antagonist compounds and methods of use202311,370,794Toll-like receptor antagonist compounds and methods of use202211,344,56319-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof202211,261,21119-NOR neuroactive steroids and methods of use thereof202211,241,44619-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to SAGE THERAPEUTICS INC (6)· patent assignee history
2022–2025Patents assigned to DYNAVAX TECH CORP (3)· patent assignee history
2022–2025Based in CN· patent location history
2022–2025Based in US· patent location history
2024Patents assigned to SAGE THERPEUTICS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SAGE THERAPEUTICS INC | 6 | 2022–2025 |
| DYNAVAX TECH CORP | 3 | 2022–2025 |
| SAGE THERPEUTICS INC | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 6 | 2022–2025 |
| US | 3 | 2022–2025 |